Ernexa Therapeutics Inc.
ERNA
$0.207
-$0.001-0.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -77.17% | -6.31% | 40.77% | -5.21% | -33.82% |
| Total Receivables | 2.82% | -89.47% | -76.83% | -45.75% | -55.31% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -88.37% | -60.37% | -28.13% | 47.98% | 24.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -75.50% | -32.73% | -7.92% | -5.39% | -29.84% |
|
|
|||||
| Total Current Assets | -75.50% | -32.73% | -7.92% | -5.39% | -29.84% |
| Net Property, Plant & Equipment | -97.73% | -97.65% | 3.08% | 2,992.52% | 2,528.28% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -97.20% | -98.53% | -22.93% | -21.02% | -19.39% |
| Total Assets | -89.28% | -85.23% | -1.00% | 228.68% | 120.53% |
|
|
|||||
| Total Accounts Payable | 61.29% | 49.80% | -18.02% | 41.20% | -34.14% |
| Total Accrued Expenses | -65.03% | -49.46% | -38.09% | -31.92% | -29.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.66% | -82.51% | 2,365.90% | 1,610.71% | 651.19% |
| Total Finance Division Other Current Liabilities | -99.27% | -74.81% | 19.95% | 10.66% | -75.00% |
| Total Other Current Liabilities | -99.27% | -74.81% | 19.95% | 10.66% | -75.00% |
| Total Current Liabilities | -55.30% | 3.39% | 33.98% | 43.69% | -14.12% |
|
|
|||||
| Total Current Liabilities | -55.30% | 3.39% | 33.98% | 43.69% | -14.12% |
| Long-Term Debt | -- | 828.07% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -98.55% | -98.47% | 3.09% | 4,247.80% | 3,603.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -78.11% | 1,635.74% | -50.73% | -51.25% | -57.14% |
| Total Liabilities | -92.39% | 9.09% | 27.67% | 586.71% | 361.06% |
|
|
|||||
| Common Stock & APIC | 23.27% | -2.17% | 6.45% | 6.81% | 6.66% |
| Retained Earnings | -23.83% | -24.86% | -13.66% | -13.42% | -13.12% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -23.84% | -1,374.75% | -320.62% | -146.25% | -81.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -23.84% | -1,374.75% | -320.62% | -146.25% | -81.56% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.82% | -1,374.37% | -320.54% | -146.23% | -81.56% |
|
|
|||||